Association of PSEN1 Mutation with Dementia with Lewy Bodies without Features of Alzheimer’s Disease

Main Article Content

Tanesh Ayyalu, MD Jason Fredrick, MD Neeraj Singh, MD

Abstract

Dementia with Lewy bodies affects 0.4% of people over the age of 65 each year, making it the second most common neurodegenerative form of dementia following Alzheimer’s disease. It is more commonly diagnosed over the age of 50, and in men more than in women. As a synucleinopathy, in which alpha-synuclein inclusions accumulate in neurons, dementia with Lewy bodies shares many clinical features with idiopathic Parkinson’s disease, including bradykinesia, visual hallucinations, and cognitive decline. Neuroimaging in dementia with Lewy bodies reveals occipital and parietal atrophy and hypometabolism. Some cases of dementia with Lewy bodies and idiopathic Parkinson’s disease have been shown to be associated with genetic mutations, such as in the GBA gene. In this case report, we present a unique case of a young man who started showing clinical features of dementia with Lewy bodies at the age of 43, with further confirmation of the diagnosis in neuroimaging studies. However, his genetic test results revealed the presence of a PSEN1 mutation, which has been described with Alzheimer’s disease, even though he did not show typical clinical or neuroimaging findings that matched with Alzheimer’s disease. This report reveals a potential unique association of the PSEN1 mutation with early-onset dementia with Lewy bodies, indicating that we may have an incomplete understanding of the function of such genes in cognitive development, as well as the phenotypic presentations of dementia with Lewy bodies, idiopathic Parkinson’s disease, and Alzheimer’s disease.

Keywords: PSEN1 Mutation, Dementia with Lewy Bodies, Alzheimer's Disease, Neuroimaging, Synucleinopathy, Genetic Mutations, Cognitive Decline, Early-Onset Dementia, Parkinson's Disease, Phenotypic Presentations

Article Details

How to Cite
AYYALU, Tanesh; FREDRICK, Jason; SINGH, Neeraj. Association of PSEN1 Mutation with Dementia with Lewy Bodies without Features of Alzheimer’s Disease. Medical Research Archives, [S.l.], v. 12, n. 6, june 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5511>. Date accessed: 22 july 2024. doi: https://doi.org/10.18103/mra.v12i6.5511.
Section
Case Reports

References

1. Boot BP, Orr CF, Ahlskog JE, et al. Risk factors for dementia with Lewy bodies: a case-control study. Neurology. 2013;81(9):833-840. doi:10.1212/WNL.0b013e3182a2cbd1

2. Chia R, Sabir MS, Bandres-Ciga S, et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021;53(3):294-303. doi:10.1038/s41588-021-00785-3

3. Clarimón J, Molina-Porcel L, Gómez-Isla T, et al. Early-onset familial Lewy body dementia with extensive Tauopathy: A clinical, genetic, and neuropathological study. Journal of Neuropathology & Experimental Neurology. 2009;68(1):73-82. doi:10.1097/nen.0b013e3181927577

4. Gomperts SN. Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia. Continuum. 2016 Apr;22(2 Dementia):435-63. doi: 10.1212/CON.0000000000000309

5. Gondim DD, Oblak A, Murrell JR, et al. Diffuse Lewy body disease and Alzheimer disease: Neuropathologic phenotype associated with the PSEN1 P.A396T mutation. Journal of Neuropathology & Experimental Neurology. 2019;78(7):585-594. doi:10.1093/jnen/nlz039

6. McKeith I, Boeve B, et. al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 4;89(1): 88-100. doi: 10.1212/WNL.0000000000004058.

7. Orme T, Guerreiro R, Bras J. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions. Curr Neurol Neurosci Rep. 2018;18(10):67. Published 2018 Aug 10. doi:10.1007/s11910-018-0874-y

8. Picková T, Matěj R, Bezdicek O, et al. Genetic Alzheimer disease and sporadic dementia with Lewy bodies: A comorbidity presenting as primary progressive aphasia. Cognitive and Behavioral Neurology. 2017;30(1):23-29. doi:10.1097/wnn.0000000000000116

9. Stinton C, McKeith I, et. al. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. American Journal of Psychiatry. 2015 Aug 1;172(8):731-42. doi: 10.1176/appi.ajp.2015.14121582

10. Yousaf T, Dervenoulas G, et. al. Neuroimaging in Lewy body dementia. Journal of Neurology. 2019; 266(1): 1–26. doi: 10.1007/s00415-018-8892-x